
OC Replay
Featuring some of our most popular online content

Biosimilar for Patients on Denosumab
Join Dr. Teri Charrois who will discuss what a biologic and biosimilar are, how they differ from one another, what you need to know when speaking with your healthcare provider and more.

Information for Healthcare Providers on the Health Canada Recently Approved Biosimilar For Denosumab
Join Dr. Angela Cheung as she speaks to how the denosumab biosimilar compares to the reference drug, what physicians can expect from the clinical results, information on treatment plans, what healthcare providers need to communicate with their patients and more.

Biologics & Biosimilars – An Overview for Healthcare Providers
Join Dr. Alan Low as he shares information on Biologics & Biosimilars – An Overview for Healthcare Providers. Information presented will include how biologics and biosimilars work, the benefits of biosimilars and how to speak to patients about these new treatment options.

Common Questions About Osteoporosis and Drug Therapies
There are many questions for those taking osteoporosis medications and treatments including why they are being prescribed, concerns over side effects and the importance of sticking to a medication schedule.

Osteoporosis and Medications: Top 5 Things to Know
Dr. Teri Charrois, BScPharm, MSc, EdD shares information on the top 5 things that you should know about osteoporosis and medications.